Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population

Brain Research Bulletin

Volumn 64, Issue 1, 2004, Pages 9-13

  Tajouri, Lotti ^a   Martin, Virginie ^a   Ovcaric, Micky ^a   Curtain, Rob P ^a   Lea, Rod A ^a,b   Csurhes, Peter ^c   Pender, Michael P ^c   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Gene association; iNOS; Multiple sclerosis; Polymorphism

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FISHER EXACT TEST; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROMOTER REGION; RELAPSE;

ADOLESCENT; ADULT; ALLELES; AUSTRALIA; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MULTIPLE SCLEROSIS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 3242709472     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2004.04.019     Document Type: Article

References (28)

1. Balashov K.E., Rottman J.B., Weiner H.L., Hancok W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U.S.A. 96(12):1999;6873-6878
2. L.F. Barcellos, A.B. Begovich, S.J. Caillier, S. Schmidt, D. Brassat, B.A.C. Cree, L. Steiner, M.A. Pericak-Vance, J.L. Haines, H.A. Erlich, R. Reynolds, S.L. Hauser, J.R. Oksenberg, MS Genetics Group. Linkage and association to the NOS2A locus on ch.17q11 in multiple sclerosis (MS). In: The American Society of Human Genetics 53rd Annual Meeting, November 2003.
3. Bellamy R., Hill A.V. Bi-allelic tetranucleotide repeat in the promoter of the human inducible nitric oxide synthase gene. Clin. Genet. 52(3):1997;192-193
4. Blanco Y., Yague J., Graus F., Saiz A. No association of inducible nitric oxide synthase gene (NOS2A) to multiple sclerosis. J. Neurol. 250(5):2003;598-600
5. Boullerne A.I., Petry K.G., Meynard M., Geffard M. Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine. J. Neuroimmunol. 60(1/2):1995;117-124
6. Calabrese V., Scapagnini G., Ravagna A., Bella R., Foresti R., Bates T.E., Guiffrida Stella A.M., Pennisi G. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J. Neurosci. Res. 70(4):2002;580-587
7. Crusius J.B., Pena A.S., Van Oosten B.W., Bioque G., Garcia A., Dijkstra C.D., Polman C.H. Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet. 346(8980):1995;979
8. Danilov A.I., Andersson M., Bavand N., Wiklund P., Olsson T., Brundin L. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J. Neuroimmunol. 136(1-2):2003;112-118
9. Fogdell-Hahn A., Ligers A., Gronning M., Hillert J., Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens. 55(2):2000;140-148
10. Fostermann U., Kleinert H. Nitric oxide synthase: expression and expressional control of three isoforms. Naunyn. Schmiedebergss. Arch. Pharmacol. 352(4):1995;351-364
11. GAMES and the Transatlantic Multiple Sclerosis Genetics Cooperative, A meta-analysis of whole genome linkage screens in multiple sclerosis, J Neuroimmunol. 143 (2003) 39-46.
12. Hua L.L., Liu J.S., Brosnan C.F., Lee S.C. Selective inhibition of human glial inducible nitric oxide synthase by interferon-beta: implications for multiple sclerosis. Ann. Neurol. 43(3):1998;384-387
13. Lea R.A., Curtain R.P., Shepherd A.G., Brimage P.J., Griffiths L.R. No evidence for involvement of the human inducible nitric oxide synthase (iNOS) gene in susceptibility to typical migraine. Am. J. Med. Genet. 105(1):2001;110-113
14. Ligers A., Xu C., Saarinen S., Hillert J., Orelup O. The CTLA-4 gene is associated with multiple sclerosis. J. Neuroimmunol. 97(1/2):1999;182-190
15. Liu J.S., Lee S.C., Battistini L., Brosnan C.F. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 158(6):2001;2057-2066
16. López-Moratalla N., González A., Aymerich M.S., López-Zabalza M.J., Pío R., de Castro P., Santiago E. Monocyte inducible nitric oxide synthase in multiple sclerosis: regulatory role of nitric oxide. NITRIC OXIDE: Biol. Chem. 1:1996;95-104
17. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151(4):1993;2132-2141
18. Modin H., Dai Y., Masterman T., Svejgaard A., Sørensen P.S., Oturai A., Ryder L.P., Spurkland A., Vartdal F., Laaksonen M., Sandberg-Wollheim M., Myhr K.M., Nyland H., Hillert J. No linkage or association of nitric oxide synthase genes to multiple sclerosis. J. Neuroimmunol. 119:2001;95-100
19. Myhr K.M., Raknes G., Nyland H., Vedeler C. Immunoglobulin G Fc-receptor (FcgammaR) IIA and IIIB polymorphisms related to disability in MS. Neurology. 52(9):1999;1771-1776
20. Nazliel B., Taskiran T.D., Irkec C., Kutay F., Pogun S. Serum nitric oxide metabolites in patients with multiple sclerosis. J. Clin. Neurosci. 9(5):2002;530-532
21. Niino M., Kikuchi S., Fukazawa T., Yabe I., Tashiro K. Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients. J. Neuroimmunol. 136(1/2):2003;125-129
22. Nunokawa Y., Ishida N., Tanaka S. Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem. Biophys. Res. Commun. 200(2):1994;802-807
23. Okuda Y., Nakatsuji Y., Fujimura H., Esumi H., Ogura T., Yanagihara T., Sakpda S. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62(1):1995;103-112
24. Sadovnick A.D., Amstrong H., Rice G.P., Bulman D., Hashimoto L., Paty D.W., Hashimoto S.A., Warren S., Hader W., Murray T.J., Seland T.P., Metz L., Bell R., Duquette P., Gray T., Nelson R., Weinshenker B., Brunet D., Ebers G.C. A population-based study of multiple sclerosis in twins: update. Ann. Neurol. 33(3):1993;281-285
25. Storch M., Lassmann H. Pathology and pathogenesis of demyelinating diseases. Curr. Opin. Neurol. 10(3):1997;186-192
26. Teixeira S.A., Castro G.M., Papes F., Martins M.L., Rogério F., Langone F., Santos L.M.B., Arruda P., de Nucci G., Muscará M.N. Expression and activity of nitric oxide synthase isoforms in rat brain during the development of experimental allergic encephalomyelitis. Brain Res. Mol. Brain Res. 99(1):2002;17-25
27. Weinshenker B.G. Natural history of multiple sclerosis. Ann. Neurol. 36(Suppl):1994;S6-S11
28. Xu W., Charles I.G., Liu L., Moncada S., Emson P. Molecular cloning and structural organization of the human inducible nitric oxide synthase gene (NOS2). Biochem. Biophys. Res. Commun. 219(3):1996;784-788